NCT03917004

Brief Summary

The investigators study 160 patients undergoing spinal surgery.Participants will be randomly divided into study group and control group.The study group will receive controlled hypotension by nitroglycerin and be divided into 3 groups according to CI.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 5, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

6 months

First QC Date

March 5, 2019

Last Update Submit

April 12, 2019

Conditions

Keywords

controlled hypotensioncardiac output onblood losssurgical fieldoxygen supplyoxygen consumption

Outcome Measures

Primary Outcomes (10)

  • cardiac index(CI) after the participants are taken into the operating room

    CI(L/min/m\^2)

    during surgery

  • cardiac index(CI) after the induction

    cardiac index (CI,L/min/m\^2)

    during surgery

  • cardiac index(CI) at 5 minutes after tubation

    cardiac index (CI,L/min/m\^2)

    5 minutes after tubation

  • cardiac index(CI) at 10 minutes after tubation

    cardiac index (CI,L/min/m\^2).

    10 minutes after tubation

  • cardiac index(CI) at 15 minutes after tubation

    cardiac index (CI,L/min/m\^2)

    15 minutes after tubation

  • cardiac index(CI) at 30 minutes after tubation

    cardiac index (CI,L/min/m\^2)

    30 minutes after tubation

  • cardiac index(CI) at 45 minutes after tubation

    cardiac index (CI,L/min/m\^2)

    45 minutes after tubation

  • cardiac index(CI) at the end of surgery

    cardiac index (CI,L/min/m\^2).

    at the end of surgery

  • cardiac index(CI) at 1 minute after extubation

    cardiac index (CI,L/min/m\^2)

    1 minute after extubation

  • cardiac index(CI) at 5 minutes after extubation

    cardiac index (CI,L/min/m\^2)

    5 minutes after extubation

Secondary Outcomes (120)

  • Partial pressure of oxygen after the participants are taken into the operating room

    during surgery

  • Arterial oxygen saturation after the participants are taken into the operating room

    during surgery

  • Arterial blood hemoglobin after the participants are taken into the operating room

    during surgery

  • Arterial blood lactate after the participants are taken into the operating room

    during surgery

  • Partial pressure central venous oxygen after the participants are taken into the operating room

    during surgery

  • +115 more secondary outcomes

Other Outcomes (30)

  • Scores of surgical field quality after the induction

    during surgery

  • Scores of surgical field quality at 5 minutes after tubation

    5 minutes after tubation

  • Scores of surgical field quality at 10 minutes after tubation

    10 minutes after tubation

  • +27 more other outcomes

Study Arms (2)

hypotension group (group H )

EXPERIMENTAL

particcipants in hypotension group are received controlled hypertension in the operation.

Drug: Nitroglycerin

control group (group C )

NO INTERVENTION

participants in cotrol group are received no controlled hypertension in the operation

Interventions

The starting rate of "nitroglycerin" was 0.25 μg / kg / min and the mean arterial pressure (MAP) decreased to 80% of the baseline but not less than 70%.The drug infusion rate was adjusted so that the MAP was maintained in the range to the suture, and the administration was stopped and the blood pressure was gradually returned to the pre-depressurization level.

Also known as: Controlled Hypotension
hypotension group (group H )

Eligibility Criteria

Age35 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 35 and 70 years
  • Patients, undergoing canal decompression, intervertebral disc extraction and pedicle screw fixation (1 vertebral body)

You may not qualify if:

  • History of cardiovascular function
  • congestive heart failure \[CHF\]
  • coronary artery disease \[CAD\]
  • cerebrovascular insuffiency)
  • poorly controlled arterial hypertension
  • pre-existing coagulation defects
  • Patients taking anticoagulatory medication including aspirin
  • Patients taking corticosteroid therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou Red cross hospital

Guangzhou, Guangdong, 510220, China

RECRUITING

Related Publications (2)

  • Kako H, Gable A, Martin D, Beebe A, Thung A, Samora W, Klamar J, Bhalla T, Tobias JD. A prospective, open-label trial of clevidipine for controlled hypotension during posterior spinal fusion. J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):54-60. doi: 10.5863/1551-6776-20.1.54.

    PMID: 25859171BACKGROUND
  • Amr YM, Amin SM. Effects of preoperative beta-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside-controlled hypotension. Saudi J Anaesth. 2012 Jul;6(3):263-7. doi: 10.4103/1658-354X.101219.

    PMID: 23162401BACKGROUND

MeSH Terms

Conditions

HypotensionHemorrhage

Interventions

NitroglycerinHypotension, Controlled

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nitro CompoundsOrganic ChemicalsAnesthesia and Analgesia

Study Officials

  • Cao Yang

    Guangzhou Red Cross Hospital

    STUDY DIRECTOR

Central Study Contacts

Yang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate chief physician

Study Record Dates

First Submitted

March 5, 2019

First Posted

April 16, 2019

Study Start

April 1, 2019

Primary Completion

September 30, 2019

Study Completion

September 30, 2019

Last Updated

April 16, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations